CGP-37157
SIGMA/C8874 - ≥98% (HPLC), powder
Synonym: 7-
CAS Number: 75450-34-9
Empirical Formula (Hill Notation): C15H11Cl2NOS
Molecular Weight: 324.22
MDL Number: MFCD09055422
Linear Formula: C15H11Cl2NOS
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C15H11Cl2NOS/c16-9-5-6 |
| InChI key | KQEPIRKXSUIUTH-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Clc1ccc2NC(=O)CSC(c3ccccc |
| solubility | DMSO: ≥20 mg/mL |
| storage temp. | 2-8°C |
| Application: | CGP-37157 has been used as a mitochondrial sodium-calcium exchanger (mNCX) inhibitor to study the role of normal mitochondrial calcium dynamics in sustaining dendritic spinogenesis. |
| Biochem/physiol Actions: | Specific inhibitor of mitochondrial Na+/Ca2+ exchange as well as sarcoplasmic reticulum calcium-stimulated ATPase and possibly other calcium channels. |
| General description: | CGP-37157 is a benzothiazepine compound, which is derived from clonazepam. It functions as a sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) antagonist and ryanodine receptor channels (RyR) agonist. CGP-37157 regulates intracellular signaling of calcium in smooth, cardiac and skeletal muscle cells and non-muscle systems. |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xn,N |
| Risk Statements | 22-50 |
| Safety Statements | 61 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

